{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fskinandjointspodcast.simplecast.com%2Fepisodes%2Feadv25acnepart2-eLI2GX8s","width":444,"version":"1.0","type":"rich","title":"(PART 2) Acne in Paris: Croissants, Comedones & Cutting-Edge Care at EADV 2025","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/017450d4-6458-4a10-9297-ca289770dc2d/230542af-2179-4d01-8e30-1addf0fc12e3/acnepari.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/3c3d2c19-8661-46d0-aece-f550486ca990\" height=\"200\" width=\"100%\" title=\"(PART 2) Acne in Paris: Croissants, Comedones &amp; Cutting-Edge Care at EADV 2025\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"PART2-Acne in Paris: Croissants, Comedones & Cutting-Edge Care at EADV 2025\n\nGuests: Dr. Chloe Ward & Dr. Natalie Cunningham\nLocation: 📍 EADV 2025, Paris 🇫🇷\n\nFrom café chatter to late-breaker abstracts, this fresh field report stitches together breaking new data and what matters for acne care today. \n\nOur two Canadian derm Faculty dynamos, Dr. Chloe Ward and Dr. Natalie Cunningham, join us live from EADV 2025 to decode acne in the TikTok age. We swap “Dr. Google” for real talk on psychosocial fallout (filters, FOMO, and 4 a.m. routines), sanity-check the diet myths, and map where AI actually helps in assessment—think consistent severity tracking and smarter primary-care triage—without replacing clinical eyes (especially in richer skin tones).\n\nDrs. Ward and Cunningham unpack multimodal regimens patients can actually tolerate, topical androgen-receptor blockade at the sebaceous unit, and smarter maintenance so scars don’t steal the show. \n\nWe dig into pigment beyond classic PIH (hello, primary melanogenesis), when energy devices earn a seat (including a 1726-nm sebaceous-targeting laser), why most at-home red light is a detour, and the rare moments biologics enter the chat for overlap/refractory cases. \n\nThroughout: practical pearls and fresh evidence\n\n\n\nLearning Objectives\n\nAfter this episode, participants will be able to:\n\n🧠 Assess psychosocial burden in acne (sleep 💤, stress 😰, social media behaviors 📱) and integrate into severity and treatment decisions 🩺.\n🥗 Debunk prevalent myths (“diet cures acne” ❌) with balanced, evidence-based counseling 📖 that acknowledges diet/stress/hormones as contributors, not sole causes ⚖️.\n🧴 Design patient-centered, multimodal regimens that optimize efficacy ✅ and tolerability 🤝—leveraging combination therapy 🔗.\n🧬 Explain mechanisms (incl. topical androgen-receptor blockade at the sebaceous gland) and position them in stepwise care from induction 🚀 to maintenance 🔁.\n🎨 Differentiate pigment pathways (PIH vs. emerging primary melanogenesis) and tailor strategies for all skin tones 🌈 with rigorous photoprotection 🧢🕶️.\n🤖 Use AI judiciously for documentation 📝 and triage 🏥; recognize limitations in diverse skin tones 🌍 and keep the patient’s lived experience central ❤️.\n🛡️ Prevent scars proactively by identifying scar-risk patients early ⏱️ and escalating appropriately (e.g., isotretinoin candidacy) 🎯.\n🔦 Outline the role of energy-based devices (including the 1726-nm sebaceous-targeting laser) in reducing inflammation 🔥, erythema 🌺, and remodeling 🧱—and why most at-home red-light devices fall short 🚫🔴.\n🧬 Spot the edge cases where biologics or overlap-syndrome thinking may be appropriate 🧩, and outline key research gaps to watch 🔭 (hormonal pathways, AI validation, long-term maintenance).\n\n\n\n\n\nPerfect for\n\nDermatologists, primary-care clinicians, pharmacists, nurses, and any HCP who fields “I saw this on TikTok…” and wants practical, patient-first ways to translate Paris-level science into Monday-morning care.\n\nSupported by an IME Grant from SUN Pharma."}